- Home
- ZLAB vs DRVN Comparison
ZLAB vs DRVN Comparison
Compare ZLAB & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- DRVN
- Stock Information
- Founded
- ZLAB 2013
- DRVN 1972
- Country
- ZLAB China
- DRVN United States
- Employees
- ZLAB N/A
- DRVN N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- DRVN Automotive Aftermarket
- Sector
- ZLAB Health Care
- DRVN Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- DRVN Nasdaq
- Market Cap
- ZLAB 3.0B
- DRVN 2.6B
- IPO Year
- ZLAB 2017
- DRVN 2021
- Fundamental
- Price
- ZLAB $26.05
- DRVN $15.90
- Analyst Decision
- ZLAB Strong Buy
- DRVN Buy
- Analyst Count
- ZLAB 3
- DRVN 12
- Target Price
- ZLAB $55.00
- DRVN $17.88
- AVG Volume (30 Days)
- ZLAB 482.4K
- DRVN 514.1K
- Earning Date
- ZLAB 02-25-2025
- DRVN 02-20-2025
- Dividend Yield
- ZLAB N/A
- DRVN N/A
- EPS Growth
- ZLAB N/A
- DRVN N/A
- EPS
- ZLAB N/A
- DRVN 0.03
- Revenue
- ZLAB $355,748,000.00
- DRVN $2,329,148,000.00
- Revenue This Year
- ZLAB $49.04
- DRVN $4.04
- Revenue Next Year
- ZLAB $46.70
- DRVN $7.93
- P/E Ratio
- ZLAB N/A
- DRVN $418.78
- Revenue Growth
- ZLAB 35.01
- DRVN 1.71
- 52 Week Low
- ZLAB $13.48
- DRVN $10.59
- 52 Week High
- ZLAB $36.60
- DRVN $17.45
- Technical
- Relative Strength Index (RSI)
- ZLAB 50.14
- DRVN 49.48
- Support Level
- ZLAB $23.82
- DRVN $15.40
- Resistance Level
- ZLAB $25.64
- DRVN $15.91
- Average True Range (ATR)
- ZLAB 1.24
- DRVN 0.37
- MACD
- ZLAB 0.06
- DRVN -0.01
- Stochastic Oscillator
- ZLAB 64.45
- DRVN 62.07
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes.